Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
about
Pneumonia in the neutropenic cancer patientPerformance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosisMolecular and nonmolecular diagnostic methods for invasive fungal infections.Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosisPractice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosis.Biomarkers for invasive aspergillosis: the challenges continue.Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2)Nationwide Surveillance of Azole Resistance in Aspergillus DiseasesIncidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort studyAspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.Galactomannan enzymatic immunoassay cross-reactivity caused by Prototheca species.Azole resistance in Aspergillus fumigatus from bronchoalveolar lavage fluid samples of patients with chronic diseases.Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation.Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.Current challenges in the microbiological diagnosis of invasive aspergillosis.Non-cultural methods for the diagnosis of invasive fungal disease.Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Diagnostics and susceptibility testing in Aspergillus.Early diagnosis of invasive mould infections and disease.H-ficolin binds Aspergillus fumigatus leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses.The serum opsonin L-ficolin is detected in lungs of human transplant recipients following fungal infections and modulates inflammation and killing of Aspergillus fumigatus.Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status.Nucleic acid amplification methodologies for the detection of pulmonary mold infections.Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.Effect of involved Aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis.Cart before the horse: use of Aspergillus PCR to increase the diagnostic yield from BAL in hematological patients at risk of invasive aspergillosis.Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.The current management landscape: aspergillosis.Comments on ''Detection of galactomannan in the bronchoalveolar lavage of high-risk patients with invasive aspergillosis admitted at the intensive care unit'' by Khodavaisy et alSensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy.Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan.Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients.Evaluation of a commercial quantitative Aspergillus fumigatus-specific IgM assay for the diagnosis of invasive pulmonary aspergillosis.Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.
P2860
Q26827758-C913CF54-B557-43B1-9BE8-EF5DFAA9F481Q33703531-D31F01F6-BCFE-43B6-8E26-658E1958557EQ33851382-5A43722C-C21B-47F2-8F69-ACB4A9E13AE1Q34057660-CA9068A5-C157-44E7-862A-C150E7DDD145Q34385038-9D6DB1F9-947B-44F6-BF4E-3430D6029015Q34532546-440924E3-D531-44A2-939D-EDFC78113874Q34565293-538A9E1A-C3E5-4FD8-AA0D-B56A67ADEDE2Q35142428-D144AF73-8F2D-4DA7-A242-C012C7004D65Q35678921-02A6B912-8F87-4B21-ACF4-E1984A1EF0DDQ35860149-1EFA4C4E-8C9D-46AB-A1DA-E08559D9B397Q35881360-22943122-0928-487C-88BD-AC20C2F8118BQ36094242-A8859AF1-EE87-4E3B-8DF5-1A464AC6FCDCQ36276975-5A29834A-F9D6-42ED-AFB9-BFE4858A4E30Q37603643-81C4F711-DAAF-43B9-BCD6-6A772F8AF633Q38091055-E1F1483E-E6F0-4E16-9716-24D02F4D9507Q38116964-738A101B-2F5E-4118-8454-F2E6BDCADE8BQ38221673-F646467E-9FE0-4373-BD87-B78533941EE4Q38266817-ADE9923B-9B96-45BD-B1FA-5D4C1C368125Q38376028-590DCFBC-4EB7-4973-B88B-0712C698F1EBQ38508539-4186012C-5F34-4855-839B-0D94F6E55A62Q38723910-C143CDF0-34CD-4273-8C75-461C1CA7B218Q38738085-EC429548-7D3B-4BE6-B11D-E284DE2EB2EFQ38858100-B5FD4292-BDAC-49FE-88B9-94D170953C25Q38917478-4EE45C50-509D-4BBD-8B88-0A9E257B060DQ39062930-1EB501A0-7F9B-4E64-91CE-C10EFB262C98Q39144117-B2531404-0D1C-42B8-97D3-31A744F5F867Q39367515-0DDD8163-71FD-489E-B4A0-C8FC62790412Q40141118-D7E43747-0756-4F41-B3ED-5DBEA3CDA363Q40187980-E73678B2-15F9-4C8F-8B09-FA74A9B5952EQ40252332-35BB24A3-7723-4734-BF9B-E33E7DF68701Q40279058-08DDB718-E6EE-4673-98F9-B2FA655F0254Q40438379-2D22895C-7291-4D62-8498-0D11369CC8B7Q41006487-E22D32AB-ABE2-41EC-B648-9E32F8298885Q42273814-62AAAB7A-5610-4262-9509-B9F4D5529E3EQ47108135-8D3C4E08-A886-4E85-99C8-B23AAE91C150Q47139903-8A1E62A1-0026-4FAA-A79F-A3620A756FDDQ47169634-83888B97-4BB9-45C1-9777-8A9497365A7BQ47314392-1E48D241-E152-4182-B77F-85D1B06FBBA5Q47640226-B2B61B3B-1BA4-4FC4-BF15-8AEFE23FA43FQ47698782-296AB5AE-DF48-4962-8533-ACDB5AE7C566
P2860
Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Detection of galactomannan in ...... lytical and clinical validity.
@ast
Detection of galactomannan in ...... lytical and clinical validity.
@en
type
label
Detection of galactomannan in ...... lytical and clinical validity.
@ast
Detection of galactomannan in ...... lytical and clinical validity.
@en
prefLabel
Detection of galactomannan in ...... lytical and clinical validity.
@ast
Detection of galactomannan in ...... lytical and clinical validity.
@en
P2093
P2860
P356
P1476
Detection of galactomannan in ...... lytical and clinical validity.
@en
P2093
Edith Vermeulen
Greet De Vlieger
Hélène Schoemans
Johan Maertens
Jorien D'Haese
Katrien Lagrou
Koen Theunissen
Liesbet Lammertijn
Philippe Meersseman
Wouter Meersseman
P2860
P304
P356
10.1128/JCM.06423-11
P407
P577
2012-02-01T00:00:00Z